Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Usonis, Vytautas ^a   Anca, Ioana ^b   André, Francis ^c   Chlibek, Roman ^d   Ivaskeviciene, Inga ^a   Mangarov, Atanas ^e   Mészner, Zsófia ^f   Prymula, Roman ^d,g   Šimurka, Pavol ^h   Tamm, Eda ⁱ   Tešović, Goran ^j  

^a VILNIUS UNIVERSITY   (Lithuania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF DEFENCE   (Czech Republic)

^d UNIVERSITY OF DEFENCE   (Czech Republic)

^e Infectious Diseases Hospital   (Bulgaria)

^f National Institute of Child Health   (Hungary)

^g University Hospital   (Slovakia)

^h University Hospital Trencin   (Slovakia)

ⁱ TARTU UNIVERSITY HOSPITAL   (Estonia)

^j Croatia   (Croatia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

ARTICLE; CHILD; CHILD CARE; CLINICAL TRIAL; CONTROL STRATEGY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG APPROVAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; EUROPE; FEVER; GUILLAIN BARRE SYNDROME; HEALTH CARE COST; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE INFLAMMATION; MASS IMMUNIZATION; NONHUMAN; OTITIS MEDIA; PNEUMONIA; PRACTICE GUIDELINE; SEASONAL INFLUENZA; SINGLE DRUG DOSE; SKIN DISCOMFORT; SKIN PAIN; SKIN REDNESS; TREATMENT PLANNING; VIRUS STRAIN; VIRUS TRANSMISSION; ADOLESCENT; INFANT; METHODOLOGY; PRESCHOOL CHILD; REVIEW; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EUROPE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 77953347125     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-168     Document Type: Article

References (57)

1. World Health Organization Fact sheet No 211. World Health Organization., http://www.who.int/mediacentre/factsheets/fs211/en/index.html
2. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007, 357(14):1373-1381. 10.1056/NEJMoa070844, 17914038.
3. Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004, 190(1):1-10. 10.1086/421274, 15195237.
4. Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002, 20(19-20):2562-2578. 10.1016/S0264-410X(02)00154-8, 12057614.
5. Tsolia MN, Logotheti I, Papadopoulos NG, Mavrikou M, Spyridis NP, Drossatou P, Kafetzis D, Konstantopoulos A. Impact of influenza infection in healthy children examined as outpatients and their families. Vaccine 2006, 24(33-34):5970-5976. 10.1016/j.vaccine.2006.05.006, 16759761.
6. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J 1997, 16(11):1065-1068. 10.1097/00006454-199711000-00012, 9384341.
7. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993, 110(1):145-160. 10.1017/S0950268800050779, 2271959, 8432318.
8. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(RR-8):1-52.
9. National Advisory Committee on Immunization (NACI) Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008, 34(ACS-3):1-46. National Advisory Committee on Immunization (NACI).
10. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, . VENICE project gatekeepers National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008, 13(43):pii: 19017. VENICE project gatekeepers., http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19017
11. Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, Kainulainen L, Puhakka T, Jartti T, Toikka P, Lehtinen P, Routi T, Juven T. Burden of influenza in children in the community. J Infect Dis 2004, 190(8):1369-1373. 10.1086/424527, 15378427.
12. Heikkinen T, Booy R, Campins M, Finn A, Olcen P, Peltola H, Rodrigo C, Schmitt HJ, Schumacher F, Teo S, Weil-Olivier C. Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur J Pediatr 2006, 165(4):223-228. 10.1007/s00431-005-0040-9, 16369798.
13. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, Herrera G, Erdman D, Hall CB, Seither R, Griffin MR. The underrecognized burden of influenza in young children. N Engl J Med 2006, 355(1):31-40. 10.1056/NEJMoa054869, 16822994.
14. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL, Klimov A, Lindstrom SE, Balish A, Medina MJ, Wallis TR, Guarner J, Paddock CD, Shieh WJ, Zaki SR, Sejvar JJ, Shay DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005, 353(24):2559-2567. 10.1056/NEJMoa051721, 16354892.
15. Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, Wright PF. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002, 185(2):147-152. 10.1086/338363, 11807687.
16. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000, 342(4):225-231. 10.1056/NEJM200001273420401, 10648763.
17. Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009, 28(5):372-375. 10.1097/INF.0b013e318191eef7, 19295464.
18. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48(8):1003-1032. 10.1086/598513, 19281331.
19. Peltola V, Reunanen T, Ziegler T, Silvennoinen H, Heikkinen T. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005, 41(8):1198-1200. 10.1086/444508, 16163640.
20. Shuler CM, Iwamoto M, Bridges CB, Marin M, Neeman R, Gargiullo P, Yoder TA, Keyserling HL, Terebuh PD. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 2007, 119(3):e587-595. 10.1542/peds.2006-1878, 17332179.
21. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008, (2):CD004879.
22. Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 2007, 26(2):97-106. 10.1097/01.inf.0000253053.01151.bd, 17259870.
23. Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005, 23(22):2851-2861. 10.1016/j.vaccine.2004.11.053, 15780733.
24. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004, 23(3):189-197. 10.1097/01.inf.0000116292.46143.d6, 15014289.
25. Joshi AY, Iyer VN, St Sauver JL, Jacobson RM, Boyce TG. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study. Vaccine 2009, 27(33):4457-4461. 10.1016/j.vaccine.2009.05.038, 19490957.
26. Hoberman A, Greenberg DP, Paradise JL, Rockette HE, Lave JR, Kearney DH, Colborn DK, Kurs-Lasky M, Haralam MA, Byers CJ, Zoffel LM, Fabian IA, Bernard BS, Kerr JD. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003, 290(12):1608-1616. 10.1001/jama.290.12.1608, 14506120.
27. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 2005, 116(1):153-159. 10.1542/peds.2005-0049, 15995046.
28. Allison MA, Daley MF, Crane LA, Barrow J, Beaty BL, Allred N, Berman S, Kempe A. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr 2006, 149(6):755-762. 10.1016/j.jpeds.2006.06.036, 17137887.
29. France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med 2004, 158(11):1031-1036. 10.1001/archpedi.158.11.1031, 15520339.
30. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001, 20(8):733-740.
31. Bueving HJ, Bernsen RM, de Jongste JC, van Suijlekom-Smit LW, Rimmelzwaan GF, Osterhaus AD, Rutten-van Molken MP, Thomas S, van der Wouden JC. Does influenza vaccination exacerbate asthma in children?. Vaccine 2004, 23(1):91-96. 10.1016/j.vaccine.2004.03.067, 15519712.
32. van der Wouden JC, Bueving HJ, Poole P. Preventing influenza: an overview of systematic reviews. Respir Med 2005, 99(11):1341-1349. 10.1016/j.rmed.2005.07.001, 16112852.
33. Fiore AE, Bridges CB, Cox NJ. Seasonal influenza vaccines. Curr Top Microbiol Immunol 2009, 333:43-83. full_text, 19768400.
34. European Centre for Disease Prevention and Control Technical Report of the Scientific Panel on Vaccines and Immunisation. Infant and children seasonal immunisation against influenza on a routine basis during inter-pandemic period. Stockholm, January 2007. European Centre for Disease Prevention and Control., http://www.ecdc.europa.eu/en/publications/Publications/0701_TER_Scientific_Panel_on_Vaccines_and_Immunisation.pdf
35. Jordan R, Connock M, Albon E, Fry-Smith A, Olowokure B, Hawker J, Burls A. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006, 24(8):1047-1062. 10.1016/j.vaccine.2005.09.017, 16298026.
36. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981, 144(5):433-441.
37. Hall CB, Douglas RG, Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis 1979, 140(4):610-613.
38. Nicholson KG. Human influenza. Textbook of Influenza 1998, 219-264. Oxford: Blackwell Science, Nicholson KG, Webster RG, Hay AJ.
39. Monto AS, Davenport FM, Napier JA, Francis T. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970, 122(1):16-25.
40. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 344(12):889-896. 10.1056/NEJM200103223441204, 11259722.
41. Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, Waecker N, Cox NJ. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000, 284(13):1677-1682. 10.1001/jama.284.13.1677, 11015798.
42. Principi N, Esposito S, Marchisio P, Gasparini R, Crovari P. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003, 22(10 Suppl):S207-210.
43. Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006, 24(23):4934-4941. 10.1016/j.vaccine.2006.03.057, 16678945.
44. Nicoll A, Ciancio B, Tsolova S, Blank P, Yilmaz C. The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Euro Surveill 2008, 13(43):pii=19018., http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19018
45. World Health Organization Influenza vaccines - Position paper. Wkly Epidemiol Rec 2005, 80(33):279-287. World Health Organization.
46. Centers for Disease Control and Prevention Estimated influenza vaccination coverage among adults and children--United States, September 1, 2004-January 31, 2005. MMWR Morb Mortal Wkly Rep 2005, 54(12):304-307. Centers for Disease Control and Prevention.
47. Abramson JS, Neuzil KM, Tamblyn SE. Annual universal influenza vaccination: ready or not?. Clin Infect Dis 2006, 42(1):132-135. 10.1086/498514, 16323103.
48. Ashkenazi S, Vertruyen A, Aristegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kuhr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006, 25(10):870-879. 10.1097/01.inf.0000237829.66310.85, 17006279.
49. Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(7):685-696. 10.1056/NEJMoa065368, 17301299.
50. Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006, 118(6):2298-2312. 10.1542/peds.2006-0725, 17142512.
51. Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan D T, Podda A. Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant. Pediatr Infect Dis J 2009, 28(7):563-571. 10.1097/INF.0b013e31819d6394, 19561422.
52. GlaxoSmithKline Clinical Study Register. Study No.: 113462 (FLU D-PAN H1N1-009). GlaxoSmithKline., http://www.gsk-clinicalstudyregister.com/files/pdf/27868.pdf
53. Ambrose CS, Yi T, Walker RE, Connor EM. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008, 27(8):744-748. 10.1097/INF.0b013e318174e0f8, 18600188.
54. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine 2008, 26(Suppl 4):D10-16. 10.1016/j.vaccine.2008.06.083, 18611422.
55. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009, 58(6):446-458. 10.1016/j.jinf.2009.04.001, 19446340.
56. VENICE (Vaccine European New Integrated Collaboration Effort) Report on National Seasonal Influenza Vaccination Survey in Europe, 2007. Work Package No. 3. VENICE (Vaccine European New Integrated Collaboration Effort)., http://venice.cineca.org/Influenza_Study_Report_v1.0.pdf
57. Vaccinnet Romania. , http://www.vaccinnet.ro/